KalVista Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (KALV)

CUSIP: 483497103

Q4 2024 13F Holders as of 31 Dec 2024

Holder snapshot 7 signals
Share change
+4,688,343
Put/Call ratio
271%
SEC-reported price per share
$8.47
Number of holders
129
Value change
+$30,397,001
Number of buys
69
Open additional details 1 more signal available
Number of sells
46
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
54,311,522

Security key

483497103

Report period

Q4 2024

Institutions

129

Top holders

10

Ownership snapshot

Top reported holders of KALV - KalVista Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Venrock Adviser, LLC
Disclosed value leader
Venrock Adviser, LLC
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F Lead comparable stake: 12% Showing 1-6 of 15 holder rows.

Quick read

Venrock Adviser, LLC leads the comparable SEC ownership view at 12%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Venrock Adviser, LLC's linked filing trail.
Comparable ownership Top 5
Venrock Adviser, LLC 12%
TANG CAPITAL MANAGEMENT LLC 8%
SUVRETTA CAPITAL MANAGEMENT, LLC 7.8%
Vestal Point Capital, LP 7.4%
Frazier Life Sciences Management,... 6.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Venrock Adviser, LLC
13F
Company
13F
12%
$72,371,885
6,249,731 shares
30 Sep 2024
TANG CAPITAL MANAGEMENT LLC
13F
Company
13F
8%
$50,043,514
4,321,547 shares
30 Sep 2024
SUVRETTA CAPITAL MANAGEMENT, LLC
13F
Company
13F
7.8%
$48,775,018
4,212,005 shares
30 Sep 2024
Vestal Point Capital, LP
13F
Company
13F
7.4%
$46,320,000
4,000,000 shares
30 Sep 2024
Frazier Life Sciences Management, L.P.
13F
Company
13F
6.8%
$42,705,500
3,687,867 shares
30 Sep 2024
Capital World Investors
13F
Company
13F
6.2%
$39,071,661
3,374,064 shares
30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
129
Shares
55,190,249
Rows available
129
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
120
Q4 2024 holders
129
Holder diff
9
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 value Q4 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .